Replies to post #170280 on Biotech Values

[DewDiligence]

EVGN—I already have three large ag positions in my portfolio (MON, DE, and ZTS), but I wouldn't mind adding a fourth. I think ag is going to be one of the strongest beneficiaries of The Global Demographic Tailwind during the next 10 years or so.

[DewDiligence]

EVGN ends 1st day on NYSE @$17.32, +17% from the US IPO price of $14.75. The $17.32 close is +6% and +10%, respectively, relative to yesterday’s ($16.28) and today’s ($15.79) closing price on the TASE, at the current exchange rate.

It looks like EVGN’s bankers left a little money on the table when they reduced the IPO price at the last minute to get the deal done.

[DewDiligence]

Do you still own EVGN? I don't own it, but I've been following the company since its IPO. The 1Q15 CC went beyond the usual boilerplate stuff and is worth a listen, IMO.